Literature DB >> 20675327

Damage control in the management of ruptured abdominal aortic aneurysm: preliminary results.

Matthew D Tadlock1, Michael J Sise, Steven T Riccoboni, C Beth Sise, Daniel I Sack, Robert G Sise, Jack C Yang, Jeffrey J Borut, Bryan S King.   

Abstract

BACKGROUND: This study compared damage control measures (DCM), including operative techniques (DCO) and resuscitative measures (DCR), with standard treatment (ST) for ruptured abdominal aortic aneurysm (rAAA).
METHODS: Historical cohort study methodology was used to evaluate outcomes for rAAA repairs related to DCM or ST over a 74-month period at a level I trauma center.
RESULTS: Of 28 repairs, 13 (46.4%) were DCM. Compared to ST patients, DCM patients had a lower mean preoperative BP (64.6 vs. 83.2 mm Hg, P = .03) and greater intraoperative blood loss (4.6 vs. 2.1 liters, P = .033). Patients who had both DCR and DCO (DCO & DCR) received more plasma (6.8 vs 2.6 units, P = .039) and less crystalloid (2.8 vs 10.5 liters, P = .005) than those receiving DCO only. A modest decrease in mortality was seen in the DCO & DCR group compared to DCO only. No DCO-related graft infections were observed.
CONCLUSION: DCR use may prove beneficial in the management of rAAA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675327     DOI: 10.1177/1538574410375132

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  2 in total

1.  Damage Control Surgery for Non-traumatic Abdominal Emergencies.

Authors:  Edouard Girard; Julio Abba; Bastien Boussat; Bertrand Trilling; Adrian Mancini; Pierre Bouzat; Christian Létoublon; Mircea Chirica; Catherine Arvieux
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

Review 2.  Systematic review of plasma/packed red blood cell ratio on survival in ruptured abdominal aortic aneurysms.

Authors:  Amanda R Phillips; Lillian Tran; Jill E Foust; Nathan L Liang
Journal:  J Vasc Surg       Date:  2020-11-13       Impact factor: 4.268

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.